Functional fine-mapping and molecular modeling of a conserved loop epitope of the measles virus hemagglutinin protein

European Journal of Biochemistry

Volumn 270, Issue 7, 2003, Pages 1515-1527

  Pütz, Mike M ^a,b   Hoebeke, Johan ^c   Ammerlaan, Wim ^a   Schneider, Serge ^d   Muller, Claude P ^a,e  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Antibody antigen interaction; Epitope; Measles virus; Molecular modeling; Synthetic peptide

Indexed keywords

ALANINE; CYSTEINE DERIVATIVE; DIPHTHERIA TOXOID; DISULFIDE; EPITOPE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; ISOLEUCINE; LEUCINE; LYSINE; MEASLES VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BH216; NEUTRALIZING ANTIBODY; SOLVENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CROSS REACTION; DRUG CONJUGATION; DRUG STRUCTURE; EPITOPE MAPPING; HYDROPHILICITY; HYDROPHOBICITY; IMMUNIZATION; MEASLES VIRUS; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BIOSENSING TECHNIQUES; CONSERVED SEQUENCE; DISULFIDES; EPITOPES; FLOW CYTOMETRY; HEMAGGLUTININS, VIRAL; MEASLES VIRUS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN ISOFORMS; SEQUENCE HOMOLOGY, AMINO ACID; SURFACE PLASMON RESONANCE; TUMOR CELLS, CULTURED;

ANIMALIA; MEASLES VIRUS;

EID: 0344406094     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03517.x     Document Type: Article

References (46)

1. Klingele, M., Hartter, H.K., Adu, F., Ammerlaan, W., Ikusika, W. & Muller, C.P. (2000) Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody. J. Med. Virol. 62, 91-98.
2. Muller, C.P. (2001) Measles elimination: old and new challenges? Vaccine 19, 2258-2261.
3. Orenstein, W.A., Strebel, P.M., Papania, M., Sutter, R.W., Bellini, W.J. & Cochi, S.L. (2000) Measles eradication: is it in our future? Am. J. Public Health. 90, 1521-1525.
4. Strebel, P.M. & Cochi, S.L. (2001) Waving goodbye to measles. Nature 414, 695-696.
5. McFarlin, D.E., Bellini, W.J., Mingioli, E.S., Behar, T.N. & Trudgett, A. (1980) Monospecific antibody to the haemagglutinin of measles virus. J. Gen. Virol. 48, 425-429.
6. Giraudon, P. & Wild, T.F. (1985) Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46-58.
7. Fournier, P., Brons, N.H., Berbers, G.A., Wiesmuller, K.H., Fleckenstein, B.T., Schneider, F., Jung, G. & Muller, C.P. (1997) Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J. Gen. Virol. 78, 1295-1302.
8. Ziegler, D., Fournier, P., Berbers, G.A., Steuer, H., Wiesmuller, K.H., Fleckenstein, B., Schneider, F., Jung, G., King, C.C. & Muller, C.P. (1996) Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. J. Gen. Virol. 77, 2479-2489.
9. El Kasmi, K.C., Fillon, S., Theisen, D.M., Hartter, H., Brons, N.H. & Muller, C.P. (2000) Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies. J. Gen. Virol. 81, 729-735.
10. van Regenmortel, M.H. (1999) Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology. Vaccine 18, 216-221.
11. Bittle, J.L., Houghten, R.A., Alexander, H., Shinnick, T.M., Sutcliffe, J.G., Lerner, R.A., Rowlands, D.J. & Brown, F. (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298, 30-33.
12. Emini, E.A., Jameson, B.A. & Wimmer, E. (1983) Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 304, 699-703.
13. Francis, M.J., Hastings, G.Z., Clarke, B.E., Brown, A.L., Beddell, C.R., Rowlands, D.J. & Brown, F. (1990) Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology 69, 171-176.
14. Langeveld, J.P., Casal, J.I., Cortes, E., van de Wetering, G., Boshuizen, R.S., Schaaper, W.M., Dalsgaard, K. & Meloen, R.H. (1994) Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12, 1473-1480.
15. Obeid, O.E., Partidos, C.D., Howard, C.R. & Steward, M.W. (1995) Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J. Virol. 69, 1420-1428.
16. El Kasmi, K.C., Theisen, D., Brons, N.H. & Muller, C.P. (1998) The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein. Mol. Immunol. 35, 905-918.
17. Goldbaum, F.A., Schwarz, F.P., Eisenstein, E., Cauerhff, A., Mariuzza, R.A. & Poljak, R.J. (1996) The effect of water activity on the association constant and the enthalpy of reaction between lysozyme and the specific antibodies D1.3 and D44.1. J. Mol. Recognit. 9, 6-12.
18. Ochoa, W.F., Kalko, S.G., Mateu, M.G., Gomes, P., Andreu, D., Domingo, E., Fita, 1 & Verdaguer, N. (2000) A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules. J. Gen. Virol. 81, 1495-1505.
19. van Regenmortel, M.H.V. & Muller, S. (1999) Synthetic Peptides as Antigens. Elsevier, Amsterdam.
20. Richalet-Secordel, P.M., Rauffer-Bruyere, N., Christensen, L.L., Ofenloch-Haehnle, B., Seidel, C. & Van Regenmortel, M.H. (1997) Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation. Anal. Biochem. 249, 165-173.
21. Bartels, C., Stote, R.H. & Karplus, M. (1998) Characterization of flexible molecules in solution: the RGDW peptide. J. Mol. Biol. 284, 1641-1660.
22. de Swart, R.L., Vos, H.W., UytdeHaag, F.G., Osterhaus, A.D. & van Binnendijk, R.S. (1998) Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. J. Virol. Methods 71, 35-44.
23. Muller, C.P., Beauverger, P., Schneider, F., Jung, G. & Brons, N.H. (1995) Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. J. Gen. Virol. 76, 1371-1380.
24. Hu, A. & Norrby, E. (1994) Role of individual cysteine residues in the processing and antigenicity of the measles virus haemagglutinin protein. J. Gen. Virol. 75, 2173-2181.
25. Langedijk, J.P., Daus, F.J. & van Oirschot, J.T. (1997) Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J. Virol. 71, 6155-6167.
26. Fairlie, W.D., Stanton, P.G. & Hearn, M.T. (1996) Contribution of specific disulphide bonds to two epitopes of thyrotropin betasubunit associated with receptor recognition. Eur. J. Biochem. 240, 622-627.
27. Hodder, A.N., Crewther, P.E., Matthew, M.L., Reid, G.E., Moritz, R.L., Simpson, R.J. & Anders, R.F. (1996) The disulfide bond structure of Plasmodium apical membrane antigen-1. J. Biol. Chem. 271, 29446-29452.
28. Logan, D., Abu-Ghazaleh, R., Blakemore, W., Curry, S., Jackson, T., King, A., Lea, S., Lewis, R., Newman, J., Parry, N. et al. (1993) Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362, 566-568.
29. Valero, M.L., Camarero, J.A., Haack, T., Mateu, M.G., Domingo, E., Giralt, E. & Andreu, D. (2000) Native-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility. J. Mol. Recognit. 13, 5-13.
30. Nair, D.T., Singh, K., Sahu, N., Rao, K.V. & Salunke, D.M. (2000) Crystal structure of an antibody bound to an immunodominant peptide epitope: Novel features in peptide-antibody recognition. J. Immunol. 165, 6949-6955.
31. Verdaguer, N., Mateu, M.G., Andreu, D., Giralt, E., Domingo, E. & Fita, I. (1995) Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 14, 1690-1696.
32. Dokurno, P., Bates, P.A., Band, H.A., Stewart, L.M., Lally, J.M., Burchell, J.M., Taylor-Papadimitriou, J., Snary, D., Sternberg, M.J. & Freemont, P.S. (1998) Crystal structure at 1.95 A resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition. J. Mol. Biol. 284, 713-728.
33. Rini, J.M., Stanfield, R.L., Stura, E.A., Salinas, P.A., Profy, A.T. & Wilson, I.A. (1993) Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl Acad. Sci. USA 90, 6325-6329.
34. Kanyo, Z.F., Pan, K.M., Williamson, R.A., Burton, D.R., Prusiner, S.B., Fletterick, R.J. & Cohen, F.E. (1999) Antibody binding defines a structure for an epitope that participates in the PrPC - > PrPSc conformational change. J. Mol. Biol. 293, 855-863.
35. Jin, L. & Wells, J.A. (1994) Dissecting the energetics of an antibody - antigen interface by alanine shaving and molecular grafting. Protein Sci. 3, 2351-2357.
36. Benjamin, D.C. & Perdue, S.S. (1996) Site-directed mutagenesis in epitope mapping. Methods 9, 508-515.
37. Dall'Acqua, W., Goldman, E.R., Eisenstein, E. & Mariuzza, R.A. (1996) A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry 35, 9667-9676.
38. Geysen, H.M., Mason, T.J. & Rodda, S.J. (1988) Cognitive features of continuous antigenic determinants. J. Mol. Recognit. 1, 32-41.
39. Kramer, A., Keitel, T., Winlder, K., Stocklein, W., Hohne, W. & Schneider-Mergener, J. (1997) Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell 91, 799-809.
40. Ferrieres, G., Villard, S., Pugniere, M., Mani, J.C., Navarro-Teulon, I., Rharbaoui, F., Laune, D., Loret, E., Pau, B. & Granier, C. (2000) Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif. Eur. J. Biochem. 267, 1819-1829.
41. Foote, J. & Eisen, H.N. (1995) Kinetic and affinity limits on antibodies produced during immune responses. Proc. Natl Acad. Sci. USA 92, 1254-1256.
42. Möller, H., Serttas, N., Paulsen, H., Burchell, J.M., Taylor-Papadimitriou, J. & Meyer, B. (2002) NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3. Eur. J. Biochem. 269, 1444-1455.
43. Hu, A., Sheshberadaran, H., Norrby, E. & Kovamees, J. (1993) Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology 192, 351-354.
44. Liebert, U.G., Flanagan, S.G., Loffler, S., Baczko, K., ter Meulen, V. & Rima, B.K. (1994) Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J. Virol. 68, 1486-1493.
45. El Kasmi, K.C. & Muller, C.P. (2001) New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules. Vaccine 19, 2238-2244.
46. Bouche, F.B., Marquet-Blouin, E., Yanagi, Y., Steinmetz, A. & Muller, C.P. (2003) Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles. Vaccine, In press.